Theme 10 Disease stratification and phenotyping of patients

Acknowledgments:

This study was supported by the grants from the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (NRF-2017M
3C7A1025364).

Acknowledgments:

We gratefully acknowledge all the patients for participating in this protocol. This study was supported by the Association Française contre les Myopathies (AFM) and the Institut pour la Recherche sur la Moelle épinière et l’Encéphale (IRME). The research leading to these results has also received funding from the program “Investissements d’avenir”-ANR. Peter Bede is supported by the Health Research, the Irish Institute of Clinical Neuroscience IICN – Novartis Ireland Research Grant, and the Iris O’Brien Foundation Ireland.

Acknowledgments:

We thank all individuals who took part in the study. Funding was provided by MNDRIA, RBWH Foundation, MND and Me Foundation, and UQ. The authors declare no conflicts of interest.

Acknowledgments:

This work is supported by the BMBF in the framework of the JPND programme ONWebDUALS, the E-RARE programme PYRAMID, the MNDA and the DGM. The D50 global study group includes above PIs and Nayana Gaur, Benjamin Vlad, Robert Steinbach, Tino Prell, Matthieu Moisse, Umberto Manera, Marta Gromicho, Katarzyna Szacka, and Frauke Fartmann.

Acknowledgments:

This research is supported by a BMBF grant OnWebDUALS (01ED15511A) in the framework of the JPND.

Acknowledgments:

We acknowledge all the patients involved in this study. Authors declare no conflicts of interest. Funding was granted by The National Health and Medical Research Council of Australia Program Grant (#1037746).

Acknowledgments:

We would like to thank patients for donating skin biopsies. Funding was provided by MDA Young Investigator Development Grant awarded to Kathrin Meyer and the ALS Association.

Acknowledgments:

We thank the patients. This work was supported by the NIHR Sheffield Biomedical Research Centre for Translational Neuroscience, and charitable funding from the Global Challenges Research Fund.

Acknowledgments:

We extend our deep gratitude to all patients who willingly participated in this study. The study is supported by funding from the Malaysian Ministry of Education (FP043-2018A) and ALS Association. The authors declare no conflicts of interest.

Acknowledgments:

Thanks to our ALS patients and their families.

Acknowledgments:

This study was funded with the Winthrop Family Fund for ALS Science at Massachusetts General Hospital, NIH grant DP2-MH103909, and NIH-NIDCD K24DC016312.

Acknowledgments:

Funding for this project was provided by the ALS Association. Research activities were conducted in collaboration with the CReATe consortium.

Acknowledgments:

Supported by Muscular Dystrophy Association Care Center Grant, Atrium Health Foundation Carolinas ALS Funds as well as Pinstripes Foundation and ALS Charlotte Clinical Crew Funds.